LSLeonel Cardozo de Menezes e Souza

Leonel Cardozo de Menezes e Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leonel Cardozo de Menezes e Souza has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Drosophila Col4a1 Glycine mutations highlight allelic heterogeneity and mechanistic pleiotropy

    by Angus Nichols, Besaiz J. Sánchez-Sánchez, Stefania Marcotti, María-Del-Carmen Díaz-De-La-Loza, Leonel C. Menezes, Tingfei Wang, Robert M. Johnson, Brian M. Stramer


  • Open Access

    p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance

    by Leonel Cardozo de Menezes e Souza, Anderson Faletti, Carla Pires Veríssimo, Mariana Paranhos Stelling, Helena Lobo Borges

    Chemoresistance persists as a significant, unresolved clinical challenge in many cancer types. The tumor microenvironment, in which cancer cells reside and interact with non-cancer cells and tissue structures, has a known role in promoting every aspect of tumor progression, including chemoresistance. However, the molecular determinants of microenvironment-driven chemoresistance are mainly unknown. In this review, we propose that the TP53 tumor suppressor, found mutant in over half of human cancers, is a crucial regulator of cancer cell-microenvironment crosstalk and a prime candidate for the investigation of microenvironment-specific modulators of chemoresistance. Wild-type p53 controls the secretion of factors that inhibit the tumor microenvironment, whereas altered secretion or mutant p53 interfere with p53 function to promote chemoresistance. We highlight resistance mechanisms promoted by mutant p53 and enforced by the microenvironment, such as extracellular matrix remodeling and adaptation to hypoxia. Alterations of wild-type p53 extracellular function may create a cascade of spatial amplification loops in the tumor tissue that can influence cellular behavior far from the initial oncogenic mutation. We discuss the concept of chemoresistance as a multicellular/tissue-level process rather than intrinsically cellular. Targeting p53-dependent crosstalk mechanisms between cancer cells and components of the tumor environment might disrupt the waves of chemoresistance that spread across the tumor tissue, increasing the efficacy of chemotherapeutic agents.